Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

72results about How to "Reducing and preventing effect" patented technology

Apparatus and method for generating an imprint-stabilized reference voltage for use in a ferroelectric memory device

A reference voltage supply apparatus and a driving method thereof in a ferroelectric memory device provide a reference voltage stabilized against the imprint effect thus maintaining reading reliability of the device. In the reference voltage supply apparatus (e.g., using a non-switching capacitance of a ferroelectric capacitor), a reference cell is constructed of a ferroelectric capacitor and an access switch, and provides a reference voltage to read data from a memory cell. In an active mode, the reference cell stores data of a first logic state (e.g., corresponding to the non-switching capacitance of the ferroelectric capacitor), in the reference cell, and then supplies, as a reference voltage, the voltage corresponding to the data of the first logic state to a bit line; and in a stand-by mode, a reference voltage controller stores (writes) data of a second logic state (opposite to the first logic state), into the reference cell.
Owner:SAMSUNG ELECTRONICS CO LTD

Diffusion barrier for damascene structures

A damascene structure for semiconductor devices is provided. In an embodiment, the damascene structure includes trenches formed over vias that electrically couple the trenches to an underlying conductive layer such that the trenches have varying widths. The vias are lined with a first barrier layer. The first barrier layers along the bottom of vias are removed such that a recess formed in the underlying conductive layer. The recesses formed along the bottom of vias are such that the recess below narrower trenches is greater than the recess formed below wider trenches. In another embodiment, a second barrier layer may then be formed over the first barrier layer. In this embodiment, a portion of the conductive layer may be interposed between the first barrier layer and the second barrier layer.
Owner:TAIWAN SEMICON MFG CO LTD

Process for generating plasmin in the vitreous of the eye and inducing separation of the posterior hyaloid from the retina

A process for inhibiting vascular proliferation separately introduces components into the eye to generate plasmin in the eye in amounts to induce complete posterior vitreous detachment where the vitreoretinal interface is devoid of cortical vitreous remnants. The process administers a combination of lysine-plasminogen, at least one recombinant plasminogen activator selected from the group consisting of urokinase, streptokinase, tissue plasminogen activator, chondroitinase, pro-urokinase, retavase, metaloproteinase, and thermolysin and a gaseous adjuvant to form a cavity in the vitreous. The composition is introduced into the vitreous in an amount effective to induce crosslinking of the vitreous and to induce substantially complete posterior vitreous detachment from the retina without causing inflammation of the retina. The gaseous adjuvant material is introduced into the vitreous simultaneously with or after the lysine-plasminogen and recombinant plasminogen activator such as recombinant urokinase to compress the vitreous against the retina while the composition induces the complete posterior vitreous detachment.
Owner:MINU

Magnetic head for perpendicular recording with suppressed side writing and erasing

A magnetic head for perpendicular recording having reduced side writing and erasing is disclosed. The writer portion of the magnetic head includes a main pole and a return pole. The main pole includes a multilayer main pole tip and a multilayer yoke. The layers of the main pole tip and the yoke are antiferromagnetically coupled to each other with a non-magnetic metal. Antiferromagnetic coupling between the layers of the main pole tip and the yoke dramatically reduces fringing flux emanated from the sides of the main pole intending to close through an upper portion of the return pole. A biasing antiferromagnetic layer is coupled to the upper portion of the return pole to bias the return pole parallel to the air bearing surface. This prevents or reduces the effect of domain wall formation in the return pole, which results in further reduction in side writing and erasing.
Owner:SEAGATE TECH LLC

Lost Circulation Additive for Drilling Fluids

Additive for a drilling fluid to block drilling-induced or pre-existing rock fractures comprising polymeric granules with a diameter distribution peak between 1000 and 200 microns and an average resiliency of at least 10% rebound after compression by a load of 200 N and uses thereof.
Owner:MI

Milk Fat Globule Epidermal Growth Factor-Factor VIII And Sepsis

Provided are methods of treating a mammal undergoing sepsis or at risk for sepsis. Also provided are methods of preventing or treating a physiologic effect of sepsis in a mammal. Additionally provided is the use of milk fat globule epidermal growth factor-factor VIII (MFG-E8) for the manufacture of a medicament for preventing or treating a physiologic effect of sepsis in a mammal, and the use of milk fat globule epidermal growth factor-factor VIII (MFG-E8) for the treatment of a mammal having sepsis or at risk for sepsis.
Owner:THE FEINSTEIN INST FOR MEDICAL RES

Resistor Array And Semiconductor Device Including The Same

A resistor array includes a semiconductor substrate, a plurality of isolation regions, a plurality of dummy active regions and a plurality of unit resistors. The plurality of isolation regions are formed in the semiconductor substrate. The plurality of dummy active regions are formed in the semiconductor substrate between the plurality of isolation regions. The plurality of unit resistors are formed on the plurality of dummy active regions.
Owner:SAMSUNG ELECTRONICS CO LTD

Reduction of the Deleterious Effects of Tobacco Smoking

The invention features a method for inhibiting or reducing the deleterious effects of tobacco smoking including increased incidence of cancers, cardiovascular diseases, various lung disorders and the oxidative effects. The method includes the incorporation of an effective amount of a compound or a standardized plant extract that is that comprises an inhibitor of NF-κB into tobacco or a tobacco product. In particular, it relates to useful NF-κB inhibitor diterpenes and compositions containing them for incorporation into tobacco or a tobacco product.
Owner:SAVIPU PHARMA

Improved electro-thermal heating

The present invention relates to a method and controller for heating a wind turbine blade that comprises a plurality of heating zones. An icing factor is determined based on environmental conditions and one or more heating zones are determined based on the determined icing factor, wherein each heating zone comprises one or more Electro-Thermal Heating Elements. The one or more Electro-Thermal Heating Elements corresponding to the determined heating zones are activated to generate heat.
Owner:VESTAS WIND SYST AS

Circuit device and electronic apparatus

An electronic circuit includes a noise source and an analog circuit and a logic circuit that may be adversely affected by noise. At least a portion of the analog circuit and the logic circuit is formed on a buried impurity layer whose conductivity is different from that of a substrate, and at least a portion of the periphery of that portion is surrounded by an impurity layer that is different from the substrate. Thus, propagation of the noise from the noise source is prevented.
Owner:SEIKO EPSON CORP

Liquid crystal cell and a display

A liquid crystal cell (5) comprises a layer (4) of cholesteric liquid crystal material; and a retarder (3) disposed in an optical path through the layer (4) of cholesteric liquid crystal material. The cholesteric liquid crystal material is switchable between a first state in which it cooperates with the retarder (3) to provide a first viewing angle range and a second state in which it cooperates with the retarder (3) to provide a second viewing angle range which is smaller than the first viewing angle range. The pitch of the cholesteric liquid crystal material is greater than an intended wavelength of operation of the liquid crystal cell divided by the average refractive index of the liquid crystal material. The liquid crystal cell may be used as a Viewing Angle Restriction (VAR) element, to enable another component, such as a display panel (6), to be operated in either a wide viewing mode or a narrow viewing mode.
Owner:SHARP KK

Metal delivery agents and therapeutic uses of the same

The present invention relates to metal complexes, processes for their preparation and their use as pharmaceutical or veterinary agents, in particular for the treatment of conditions in which metal delivery can prevent, alleviate or ameliorate the condition. There are a number of clinical conditions which are caused by or associated with abnormal levels of metals (typically low metal levels). Conditions in of this type include cancer and conditions characterised by or associated with oxidative damage, more specifically neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease or Huntington's disease. The invention also relates to ligands useful in the preparation of metal complexes of this type.
Owner:MELBOURNE UNIV OF THE

Compositions

The present invention relates to a formulation comprising an inhibitor of NFAT activation for use in treating or preventing undesirable effects, more particularly undesirable effects occurring in conjunction with T cell-mediated therapies. The undesirable effects may be cytokine release syndrome (CRS) or symptoms associated with gastrointestinal (GI) inflammation, for example associated with inflammatory bowel diseases, such as ulcerative colitis, optionally caused by activated T cell activity. In addition to ameliorating undesirable effects, the invention is aimed at also maintaining the therapeutic effects of the T-cell mediated therapy.
Owner:SIGMOID PHARM LIMITED

Gas-assisted process for in-situ bitumen recovery from carbonate reservoirs

A method for producing bitumen or heavy oil from a subterranean reservoir comprising a carbonate mineral solid matrix comprising injection or co-injection of a gas other than carbon dioxide, injection or co-injection of a carbon containing gas containing a relatively low amount of carbon dioxide, injection of steam providing bicarbonate / alkalinity, or increasing the subterranean reservoir pressure, such that the dissolution and re-precipitation of carbonates is suppressed thereby.
Owner:THIMM ENG INC

Use of erythropoietin for the preventive or curative treatment of cardiac failure

Provided are uses of erythropoietin, or a derivative or functional analogue thereof, for the production of a medicament for the preventive or curative treatment of patients suffering from, or at risk of suffering from, cardiac failure.
Owner:STICHTING KLINISCHE FARMACOLOGIE GRONINGEN +1

Methods of preventing or reducing the affects of roof impact in automotive applications

A method of autonomously preventing or reducing the affects of roof impact in automotive applications, including the steps of determining a vehicle condition indicative of an imminent roof impact, and modifying a vehicular seat or roof structure, or deploying a netting as a result thereof, wherein active material actuation is preferably utilized to effect the same.
Owner:GM GLOBAL TECH OPERATIONS LLC

Anthrax compositions and methods of use and production

Compositions and methods effective for eliciting an immune response for preventing or reducing infection or improving clinical outcomes caused by Bacillus anthracis are provided. The compositions include a naturally occurring or synthetic protein, peptide, or protein fragment containing all or an active portion of an antigenic epitope associated with anthrax toxin proteins optionally combined with a pharmaceutically acceptable carrier. The preferred antigenic epitopes correspond to immunogenic regions of protective antigen, lethal factor or edema factor, either individually or in combination. In addition, methods and compositions containing antibodies for reducing the effects of anthrax toxins are described. The methods involve administering to a human or animal the compositions described herein in a dosage sufficient to elicit an immune response or treat the anthrax infection.
Owner:OKLAHOMA MEDICAL RES FOUND

Structure and method for III-nitride device isolation

Isolation of III-nitride devices may be performed with a dopant selective etch that provides a smooth profile with little crystal damage in comparison to previously used isolation techniques. The dopant selective etch may be an electro-chemical or photo-electro-chemical etch. The desired isolation area may be identified by changing the conductivity type of the semiconductor material to be etched. The etch process can remove a conductive layer to isolate a device atop the conductive layer. The etch process can be self stopping, where the process automatically terminates when the selectively doped semiconductor material is removed.
Owner:INFINEON TECH AMERICAS

Treatment of sepsis and inflammation with alpha2A Adrenergic antagonists

Provided are methods for treating a mammal undergoing sepsis, or at risk for sepsis. Also provided are methods of preventing or treating a physiological effect of sepsis in a mammal. Additionally provided are methods of inhibiting an inflammatory response in a mammal. Further provided is the use of an α2A-adrenergic antagonist for the manufacture of a medicament for preventing or treating a physiologic effect of sepsis in a mammal, and the use of an α2A-adrenergic antagonist for the treatment of a mammal having sepsis or at risk for sepsis.
Owner:THE FEINSTEIN INST FOR MEDICAL RES

Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2

The invention features a method for inhibiting or reducing the deleterious effects of tobacco smoking including increased incidence of cancers, cardiovascular diseases, various lung disorders and the oxidative effects. The method includes the incorporation of an effective amount of a compound or a standardized plant extract that is that comprises an inhibitor of antioxidant stress due to the induction of phase 2 enzymes regulated by Nerf2 into tobacco or a tobacco product.
Owner:SAVIPU PHARMA

Hydroxyapatite tissue filler and its preparation and use

The invention pertains to a biocompatible composition, suitable for use in soft or hard tissue augmentation, wherein the composition is an aqueous suspension containing a carrier fraction of ceramic particles of less than 15 &mgr;m and an augmentation fraction of ceramic particles of at least 20 &mgr;m. The ceramics typically comprise calcium phosphate. The composition is a may be used in soft tissue repair as well as hard bone replacement. It advantageously avoids the need for foreign body materials which are conventionally applied to stabilize augmentation suspensions.
Owner:CAM BIOCERAMICS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products